Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain

Barsony, 1997, Subcellular distribution of normal and mutant vitamin D receptors in living cells. Studies with a novel fluorescent ligand, J. Biol. Chem., 272, 5774, 10.1074/jbc.272.9.5774 Brewer, 2001, Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons, J. Neurosci., 21, 98, 10.1523/JNEUROSCI.21-01-00098.2001 Brown, 2003, 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons, Neurosci. Lett., 343, 139, 10.1016/S0304-3940(03)00303-3 Burkert, 2003, Vitamin D receptor expression in the embryonic rat brain, Neurosci. Res. Commun., 33, 63, 10.1002/nrc.10081 Carswell, 1997, Vitamin D in the nervous system: actions and therapeutic potential, 1197 Clemens, 1988, Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells, Endocrinology, 122, 1224, 10.1210/endo-122-4-1224 Cornet, 1998, 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro, J. Neurosci. Res., 53, 742, 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-# de Viragh, 1989, Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis, Proc. Natl. Acad. Sci. U.S.A., 86, 3887, 10.1073/pnas.86.10.3887 Eyles, 2003, Vitamin D3 and brain development, Neuroscience, 118, 641, 10.1016/S0306-4522(03)00040-X Fu, 1997, Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1, Mol. Endocrinol., 11, 1961, 10.1210/me.11.13.1961 Garcion, 1997, 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis, Brain Res., 45, 255, 10.1016/S0169-328X(96)00260-4 Garcion, 1998, Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3, Glia, 22, 282, 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7 Garcion, 2002, New clues about vitamin D functions in the nervous system, Trends Endocrinol. Metab., 13, 100, 10.1016/S1043-2760(01)00547-1 Griffin, 2001, Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo, Proc. Natl. Acad. Sci. U.S.A., 98, 6800, 10.1073/pnas.121172198 Hewison, 2003, Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells, J. Immunol., 170, 5382, 10.4049/jimmunol.170.11.5382 Hewison, 2004, Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase, Mol. Cell Endocrinol., 215, 31, 10.1016/j.mce.2003.11.017 Jones, 1998, Current understanding of the molecular actions of vitamin D, Physiol. Rev., 78, 1193, 10.1152/physrev.1998.78.4.1193 Kreutz, 1993, 1,25-Dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages, Blood, 82, 1300, 10.1182/blood.V82.4.1300.1300 Mackay-Sim, 2004, Schizophrenia, vitamin D, and brain development, Int. Rev. Neurobiol., 59, 351, 10.1016/S0074-7742(04)59014-1 Matkovits, 1995, Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation, Mol. Endocrinol., 9, 232, 10.1210/me.9.2.232 McGrath, 2001, Does ‘imprinting’ with low prenatal vitamin D contribute to the risk of various adult disorders?, Med. Hypotheses, 56, 367, 10.1054/mehy.2000.1226 McGrath, 2001, Vitamin D: the neglected neurosteroid?, Trends Neurosci., 24, 570, 10.1016/S0166-2236(00)01949-4 McGrath, 2003, The neurodevelopmental hypothesis of schizophrenia: a review of recent developments, Ann. Med., 35, 86, 10.1080/07853890310010005 Melcangi, 2001, Steroids in the nervous system: a Pandora's box?, Trends Neurosci., 24, 311, 10.1016/S0166-2236(00)01820-8 Moore, 1996, Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells, Clin. Exp. Metastasis, 14, 239 Musiol, 1997, 1,25-Dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs, Endocrinology, 138, 12, 10.1210/en.138.1.12 Musiol, 1992, Vitamin D nuclear binding to neurons of the septal, substriatal and amygdaloid area in the Siberian hamster (Phodopus sungorus) brain, Neuroscience, 48, 841, 10.1016/0306-4522(92)90272-4 Naveilhan, 1996, 1,25-Dihydroxyvitamin D-3, an inducer of glial cell line-derived neurotrophic factor, NeuroReport, 7, 2171, 10.1097/00001756-199609020-00023 Neveu, 1994, 1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes, NeuroReport, 6, 124, 10.1097/00001756-199412300-00032 Neveu, 1994, 1,25-Dihydroxyvitamin D-3 regulates the synthesis of nerve growth-factor in primary cultures of glial-cells, Mol. Brain Res., 24, 70, 10.1016/0169-328X(94)90119-8 Prufer, 1997, 1,25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus, Cell Mol. Biol., 43, 543 Prufer, 1999, Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord, J. Chem. Neuroanat., 16, 135, 10.1016/S0891-0618(99)00002-2 Puchacz, 1996, Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells, Brain Res. Mol. Brain Res., 36, 193, 10.1016/0169-328X(95)00314-I Riaz, 1999, A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats, Diabetologia, 42, 1308, 10.1007/s001250051443 Rupprecht, 1999, Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives, Trends Neurosci., 22, 410, 10.1016/S0166-2236(99)01399-5 Saporito, 1994, Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain, Brain Res., 633, 189, 10.1016/0006-8993(94)91539-3 Schnell, 1999, Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue, J. Histochem. Cytochem., 47, 719, 10.1177/002215549904700601 Shinpo, 2000, Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by l-buthionine sulfoximine and 1-methyl-4-phenylpyridine, J. Neurosci. Res., 62, 374, 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7 Stumpf, 1987, 1,25(OH)2 Vitamin D3 sites of action in the brain — an autoradiographic study, Histochemistry, 87, 393, 10.1007/BF00496810 Stumpf, 1982, Brain target sites for 1,25-dihydroxyvitamin D3, Science, 215, 1403, 10.1126/science.6977846 Sutherland, 1992, Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels, Brain Res. Mol. Brain Res., 13, 239, 10.1016/0169-328X(92)90032-7 Veenstra, 1998, 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo, Brain Res., 804, 193, 10.1016/S0006-8993(98)00565-4 Veenstra, 1998, 1,25-Dihydroxyvitamin D-3 receptors in the central nervous system of the rat embryo, Brain Res., 804, 193, 10.1016/S0006-8993(98)00565-4 Walbert, 2001, Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat, Horm. Metab. Res., 33, 525, 10.1055/s-2001-17210 Wang, 2001, Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats, Brain Res., 904, 67, 10.1016/S0006-8993(01)02450-7 Wang, 2000, Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats, Neuropharmacology, 39, 873, 10.1016/S0028-3908(99)00255-5 Wion, 1991, 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis, J. Neurosci. Res., 28, 110, 10.1002/jnr.490280111 Zakon, 1998, The effects of steroid hormones on electrical activity of excitable cells, Trends Neurosci., 21, 202, 10.1016/S0166-2236(97)01209-5 Zehnder, 2001, Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase, J. Clin. Endocrinol. Metab., 86, 888, 10.1210/jc.86.2.888 Zehnder, 1999, The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase, Mol. Cell Endocrinol., 151, 213, 10.1016/S0303-7207(99)00039-8